FFP for 55 patients with extranodal marginal zone lymphoma of ocular adnexa. Kaplan-Meier estimates for the proportion of progression-free patients 1, 5, and 10 years after starting treatment are 91% (95% CI: 83%-98%), 79% (95% CI: 65%-92%), and 56% (95% CI: 34%-77%), respectively.